Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

Latest News

Date posted: 1/14/2014

After facing federal criminal charges last year over the marketing of its antipsychotic drug Risperdal, pharma giant Johnson & Johnson now must deal with mounting lawsuits from patients who developed abnormal breast growth while using the medication.
 
That litigation is taking a turn for the serious as cases have spilled over into federal court and victims are demanding J&J stop concealing clinical studies that may show the true dangers of Risperdal.
 
In November, J&J pled guilty to criminal charges from the Department of Justice that it marketed Risperdal for unapproved uses, such as ADHD in children. They were forced to pay $2.2 billion in penalties as a result.
 
Now, damages from patient lawsuits could end up being nearly as costly. Risperdal has been linked to abnormal breast growth and type 2 diabetes in the very children that weren’t supposed to receive the drug to begin with.
 
Gynecomastia is a condition that can result in abnormal breast growth in children and adult males. It can also cause lactation and the need for surgery as it is non-reversable.
 
Records show hundreds of families have already filed a Risperdal lawsuit over gynecomastia in a special Pennsylvania state court. Now, a new lawsuit alleging breast growth in a 7 year old boy has been moved to a federal court in Illinois, which could bring a nationally-binding verdict.
 
Victims have also asked that early Risperdal clinical studies, which J&J has fought to keep sealed, be opened to show whether the company knew of the dangers.
 
Instead of fighting the breast growth cases and face media attention, J&J has so far settled each case before it reaches trial.
 
Risperdal is approved by the FDA for the treatment of schizophrenia, bipolar disorder and autism in adults and adolescents. However, the aggressive marketing of J&J also led to its use for less severe conditions like ADHD in thousands of children.
 
In addition to the risk of gynecomastia, a recent study from Vanderbilt University discovered children given Risperdal may have three times the risk of developing type-2 diabetes.
 
If your child suffered breast growth, lactation or diabetes after taking Risperdal, it is important to speak with a lawyer to find out if you qualify for a lawsuit and substantial compensation. It costs nothing to talk with a lawyer today or file a claim.
 
Due to the complexity of these cases, DrugRisk only recommends lawyers who have already handled Risperdal lawsuits. We are available 24 hours a day to help.